Integrated Cash And Short Term Investments vs Intangible Assets Analysis

IDHC Stock   0.40  0.02  5.26%   
Integrated Diagnostics financial indicator trend analysis is infinitely more than just investigating Integrated Diagnostics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Integrated Diagnostics is a good investment. Please check the relationship between Integrated Diagnostics Cash And Short Term Investments and its Intangible Assets accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Integrated Diagnostics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Cash And Short Term Investments vs Intangible Assets

Cash And Short Term Investments vs Intangible Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Integrated Diagnostics Cash And Short Term Investments account and Intangible Assets. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Integrated Diagnostics' Cash And Short Term Investments and Intangible Assets is -0.35. Overlapping area represents the amount of variation of Cash And Short Term Investments that can explain the historical movement of Intangible Assets in the same time period over historical financial statements of Integrated Diagnostics Holdings, assuming nothing else is changed. The correlation between historical values of Integrated Diagnostics' Cash And Short Term Investments and Intangible Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash And Short Term Investments of Integrated Diagnostics Holdings are associated (or correlated) with its Intangible Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Intangible Assets has no effect on the direction of Cash And Short Term Investments i.e., Integrated Diagnostics' Cash And Short Term Investments and Intangible Assets go up and down completely randomly.

Correlation Coefficient

-0.35
Relationship DirectionNegative 
Relationship StrengthInsignificant

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Integrated Diagnostics balance sheet. This account contains Integrated Diagnostics investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Integrated Diagnostics Holdings fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Intangible Assets

Non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value.
Most indicators from Integrated Diagnostics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Integrated Diagnostics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Integrated Diagnostics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Tax Provision is likely to gain to about 339.1 M in 2024, whereas Selling General Administrative is likely to drop slightly above 168.1 M in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit2.8B1.5B1.5B1.1B
Total Revenue5.2B3.6B4.1B2.3B

Integrated Diagnostics fundamental ratios Correlations

0.510.920.960.850.880.130.920.980.820.950.480.820.840.460.57-0.310.890.80.72-0.420.990.840.960.73-0.38
0.510.270.330.690.780.870.690.480.360.60.20.20.860.810.42-0.870.740.810.69-0.730.430.770.390.7-0.43
0.920.270.970.660.74-0.060.820.880.680.830.410.860.680.30.38-0.160.770.650.59-0.220.950.710.920.69-0.24
0.960.330.970.760.77-0.060.880.950.810.840.530.920.730.360.53-0.180.790.680.58-0.30.980.730.980.65-0.39
0.850.690.660.760.770.320.880.830.810.770.420.740.810.570.49-0.490.760.760.71-0.450.780.740.850.6-0.31
0.880.780.740.770.770.490.920.860.640.920.380.560.980.790.55-0.670.990.960.88-0.620.850.990.760.88-0.48
0.130.87-0.06-0.060.320.490.310.08-0.130.31-0.01-0.230.580.630.15-0.790.430.540.47-0.620.050.5-0.030.55-0.22
0.920.690.820.880.880.920.310.90.80.840.50.810.920.690.61-0.60.920.90.75-0.560.890.90.910.77-0.53
0.980.480.880.950.830.860.080.90.840.920.60.810.820.460.67-0.270.860.780.68-0.450.980.820.950.68-0.5
0.820.360.680.810.810.64-0.130.80.840.670.440.850.640.390.6-0.210.670.60.49-0.30.80.610.880.38-0.44
0.950.60.830.840.770.920.310.840.920.670.340.60.870.520.51-0.380.920.850.81-0.450.930.90.820.81-0.31
0.480.20.410.530.420.38-0.010.50.60.440.340.530.420.230.72-0.050.340.310.13-0.50.480.310.560.26-0.77
0.820.20.860.920.740.56-0.230.810.810.850.60.530.550.250.45-0.10.590.50.38-0.190.830.530.940.41-0.35
0.840.860.680.730.810.980.580.920.820.640.870.420.550.820.58-0.730.970.960.85-0.680.80.970.740.88-0.53
0.460.810.30.360.570.790.630.690.460.390.520.230.250.820.33-0.90.770.830.8-0.60.410.810.370.69-0.44
0.570.420.380.530.490.550.150.610.670.60.510.720.450.580.33-0.180.510.470.2-0.460.560.480.560.34-0.88
-0.31-0.87-0.16-0.18-0.49-0.67-0.79-0.6-0.27-0.21-0.38-0.05-0.1-0.73-0.9-0.18-0.65-0.79-0.70.68-0.24-0.72-0.23-0.640.33
0.890.740.770.790.760.990.430.920.860.670.920.340.590.970.770.51-0.650.960.89-0.590.870.990.780.87-0.44
0.80.810.650.680.760.960.540.90.780.60.850.310.50.960.830.47-0.790.960.91-0.690.760.990.70.86-0.44
0.720.690.590.580.710.880.470.750.680.490.810.130.380.850.80.2-0.70.890.91-0.460.680.910.580.83-0.11
-0.42-0.73-0.22-0.3-0.45-0.62-0.62-0.56-0.45-0.3-0.45-0.5-0.19-0.68-0.6-0.460.68-0.59-0.69-0.46-0.37-0.64-0.35-0.540.67
0.990.430.950.980.780.850.050.890.980.80.930.480.830.80.410.56-0.240.870.760.68-0.370.820.950.72-0.38
0.840.770.710.730.740.990.50.90.820.610.90.310.530.970.810.48-0.720.990.990.91-0.640.820.720.88-0.43
0.960.390.920.980.850.76-0.030.910.950.880.820.560.940.740.370.56-0.230.780.70.58-0.350.950.720.6-0.41
0.730.70.690.650.60.880.550.770.680.380.810.260.410.880.690.34-0.640.870.860.83-0.540.720.880.6-0.29
-0.38-0.43-0.24-0.39-0.31-0.48-0.22-0.53-0.5-0.44-0.31-0.77-0.35-0.53-0.44-0.880.33-0.44-0.44-0.110.67-0.38-0.43-0.41-0.29
Click cells to compare fundamentals

Integrated Diagnostics Account Relationship Matchups

Integrated Diagnostics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets3.8B4.2B6.2B5.3B5.8B4.1B
Short Long Term Debt Total444.8M552.1M98.1M116.4M1.2B1.2B
Other Current Liab374.0M488.3M1.4B871.0M679.8M412.0M
Total Current Liabilities828.2M1.0B2.3B1.5B1.3B880.3M
Total Stockholder Equity2.2B2.3B2.6B2.2B2.7B2.4B
Property Plant And Equipment Net1.1B1.1B1.5B1.9B2.1B2.2B
Net Debt35.9M(48.1M)(793.4M)(532.1M)504.9M530.2M
Retained Earnings456.7M603.3M1.6B783.1M1.3B1.3B
Accounts Payable145.2M177.6M311.3M269.8M271.7M165.7M
Cash408.9M600.1M891.5M648.5M674.3M572.3M
Non Current Assets Total2.7B2.8B3.2B3.7B3.8B2.8B
Non Currrent Assets Other(1K)276.6M1.5B18.1M20.8M19.7M
Cash And Short Term Investments630.5M876.8M2.4B815.9M860.5M815.7M
Net Receivables261.7M326.8M373.9M397.5M571.5M600.1M
Good Will1.3B1.3B1.3B1.3B1.3B1.4B
Liabilities And Stockholders Equity3.8B4.2B6.2B5.3B5.8B4.1B
Non Current Liabilities Total567.0M741.7M1.1B1.4B1.4B1.5B
Inventory84.3M100.1M222.6M265.5M374.7M393.4M
Other Current Assets61.4M56.7M95.9M146.4M155.7M163.5M
Other Stockholder Equity1.1B1.1B1.1B1.1B(427.1M)(405.8M)
Total Liab1.4B1.8B3.4B2.8B2.7B1.5B
Property Plant And Equipment Gross1.1B1.1B2.1B2.8B3.2B3.4B
Total Current Assets1.0B1.4B3.0B1.6B2.0B1.3B
Accumulated Other Comprehensive Income(387.7M)(482.7M)(1.1B)(780.8M)(753.2M)(715.6M)
Short Term Debt87.1M85.9M137.2M171.4M220.4M231.4M
Intangible Assets398.6M399.8M402.5M418.2M422.9M335.8M
Other Liab196.8M209.3M275.5M371.3M427.0M222.5M
Net Tangible Assets597.6M554.7M610.2M924.0M1.1B551.2M
Long Term Debt81.3M67.6M76.3M93.8M67.5M58.8M
Property Plant Equipment705.8M1.0B1.1B1.5B1.7B1.8B
Short Term Investments221.6M276.6M1.5B167.4M186.3M365.1M
Capital Lease Obligations338.1M459.0M760.7M1.1B1.1B556.7M
Net Invested Capital2.3B2.4B2.7B2.3B2.8B2.7B
Net Working Capital209.7M351.0M693.6M160.2M686.9M468.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Integrated Stock Analysis

When running Integrated Diagnostics' price analysis, check to measure Integrated Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integrated Diagnostics is operating at the current time. Most of Integrated Diagnostics' value examination focuses on studying past and present price action to predict the probability of Integrated Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integrated Diagnostics' price. Additionally, you may evaluate how the addition of Integrated Diagnostics to your portfolios can decrease your overall portfolio volatility.